iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) Stock Price Up 5.4%
iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)’s stock price traded up 5.4% on Monday . The company traded as high as $135.06 and last traded at $134.71. 4,987,996 shares were traded during trading, an increase of 43% from the average session volume of 3,499,835 shares. The stock had previously closed at $127.79.
Separately, ValuEngine downgraded shares of iShares Nasdaq Biotechnology ETF from a “hold” rating to a “sell” rating in a report on Thursday, July 2nd.
The stock’s 50 day moving average is $133.34 and its two-hundred day moving average is $127.13.
About iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)
iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.
Featured Story: Yield Curve
Receive News & Ratings for iShares Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.